Immunitrack ApS
Desconocido
ImmuniPrDx: PrDx Advanced Software for Predicting the Immune Response During Drug Development
IMMUNITRACK APS
tramitó un
H2020
H2020-EIC-SMEInst-2018-2020
>90% of drug and vaccine candidates fail during drug development, resulting in an average of €35M lost per drug for the pharma companies, an...
2019-05-11 - 2019-09-30 | Financiado
2019-05-11 - 2019-09-30 | Financiado
* No se disponen de datos de la empresa actual.